Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes

Atherosclerosis
Tomoya MitaRyuzo Kawamori

Abstract

To investigate the effect of highly purified eicosapentaenoic acid (EPA) on the progression of diabetic macroangiopathy, we performed an open-label randomized prospective trial. A total of 81 Japanese type 2 diabetes were randomly assigned to the EPA (1800 mg/day) treated group or the control group. Carotid intima-media thickness (IMT) and brachial-ankle pulse wave velocity (baPWV) were evaluated before and after treatment in both groups. Sixty patients (EPA group, n=30; control group, n=30) completed this study. During the study period of 2.1+/-0.2 years, the mean IMT and max IMT of the EPA treated group showed a significant annual decrease compared with that of the control group (mean IMT, -0.029+/-0.112 mm versus 0.016+/-0.109 mm, respectively, P=0.029; max IMT, -0.084+/-0.113 mm versus -0.005+/-0.108 mm, respectively, P=0.0008). The baPWV was also improved significantly in the EPA treated group compared with the control group (-22.1+/-127.9 cm/s versus 62.3+/-223 cm/s, respectively, P=0.021). Multiple regression analysis showed that the administration of EPA was a significant and independent factor associated with an annual improvement of mean IMT (R2=0.067). In summary, this is the first demonstration that administration o...Continue Reading

References

Mar 1, 1984·Progress in Cardiovascular Diseases·N B Ruderman, C Haudenschild
Nov 1, 1994·Circulation·A LeafA E Raizner
Jan 1, 1996·The American Journal of Cardiology·J EritslandM Abdelnoor
Mar 17, 1997·Biochemical and Biophysical Research Communications·Y OkudaK Yamashita
May 8, 1998·Diabetes Care·C E FriedbergD E Grobbee
May 11, 1999·Circulation·J BlacherG M London
Mar 19, 2002·Hypertension·Michel E SafarGérard M London
Aug 13, 2002·Journal of Hypertension·Johanna M GeleijnseFrans J Kok
Jan 3, 2004·BMJ : British Medical Journal·Jehangir N DinAndrew D Flapan

❮ Previous
Next ❯

Citations

Oct 22, 2008·Current Atherosclerosis Reports·Konstantinos TziomalosDimitri P Mikhailidis
Jan 18, 2013·Current Diabetes Reports·Charlotte JeppesenMatthias B Schulze
Jul 3, 2010·The British Journal of Nutrition·Jesper HallundLotte Lauritzen
Oct 19, 2011·The British Journal of Nutrition·Matthew P PaseJerome Sarris
Sep 19, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Noriko SatohYoshihiro Ogawa
Sep 19, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shizukiyo Ishikawa, Kazuomi Kario
Apr 15, 2010·Journal of Nutrition for the Elderly·Gwendolen Buhr, Connie W Bales
Jan 13, 2009·Current Opinion in Lipidology·Janine HartwegAndrew Neil
May 21, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuichi IshikawaUNKNOWN JELIS Investigators
Jul 23, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshikazu KashiyamaKazuhisa Kodama
Dec 4, 2010·Vascular Health and Risk Management·Katsuya SuzukiKenji Takazawa
Nov 20, 2013·Journal of Clinical Biochemistry and Nutrition·Takeshi OtsukiIchiro Kono
Nov 26, 2013·Journal of Atherosclerosis and Thrombosis·Ryo ItoAkira Shimatsu
Jan 1, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·K S PetersenJ B Keogh
Oct 21, 2014·Journal of Food Science and Technology·Narinder KaurAnil K Gupta
Jan 22, 2010·Women's Health·Jennifer G RobinsonWilliam Harris
Mar 5, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Ronald B Goldberg, Anup K Sabharwal
Nov 14, 2015·Current Medical Research and Opinion·Laurence S Sperling, John R Nelson
Mar 20, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Timothy J Lyons, Arpita Basu
Jun 15, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Yasutaka JinnoHitoshi Shimano
Feb 10, 2009·Atherosclerosis·Helen M LindqvistJohannes Hulthe
Jul 12, 2014·Atherosclerosis·Ana Luiza Teixeira dos SantosThemis Zelmanovitz
Aug 30, 2011·European Journal of Pharmacology·Osamu TakaseToshiro Fujita
Aug 25, 2015·BioMed Research International·Michela ZanettiRenzo Carretta
Feb 11, 2015·Cell Biochemistry and Biophysics·Pei-Ying Zhang
Jul 10, 2013·Diabetes Research and Clinical Practice·Kaede Ishikawa OkayamaHirotaka Watada
Nov 7, 2014·The British Journal of Nutrition·Rebecca B CostelloChristopher T Sempos
May 4, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Jonathan Fialkow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.